TrialThe oncologist2022

Management of Dermatologic Events Associated With the Nectin-4-directed Antibody-Drug Conjugate Enfortumab Vedotin.

Mario E Lacouture et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.